NGS (Next-Generation Sequencing) is a modern laboratory technology used in fertility care—most commonly within embryo genetic testing during IVF in Georgia, especially in Tbilisi. Patients often search for “NGS treatment” when they actually mean NGS-based genetic testing that supports embryo evaluation before transfer.
This SEO-focused guide explains what NGS is, how it is used in IVF genetic testing, who may benefit, how the process works step by step, and what NGS can and cannot provide—without using any reference links.
What Is NGS (Next-Generation Sequencing)?
Next-Generation Sequencing is an advanced DNA analysis method that can read genetic information in a high-throughput, detailed way. In IVF, NGS is used to analyze DNA from an embryo biopsy sample to support embryo testing strategies, most commonly for:
-
PGT-A (chromosome screening for aneuploidy)
-
PGT-M (single-gene disorder testing, depending on the plan)
-
PGT-SR (chromosomal structural rearrangements, depending on the plan)
In everyday patient language, “NGS in IVF” usually refers to using NGS as the laboratory method that generates embryo genetic testing results.
Why Patients Choose NGS in IVF in Georgia
Patients researching NGS in Georgia often want:
-
a more structured embryo selection plan
-
clearer information before embryo transfer
-
reduced uncertainty for known genetic risks
-
an advanced lab approach integrated into IVF/ICSI care in Tbilisi
It is important to understand that NGS supports decision-making, but it does not guarantee pregnancy or a live birth.
NGS vs Array CGH: What’s the Difference?
Both NGS and Array CGH can be used for embryo chromosome testing depending on laboratory workflow. The key point for patients is not just the technology name—it is:
-
the lab’s validated protocol
-
embryo biopsy quality
-
reporting standards
-
how results are used clinically for transfer planning
Your clinic will choose the most appropriate method based on lab strategy and medical indication.
Who May Benefit From NGS-Based Embryo Testing in Georgia?
NGS-based embryo testing may be discussed more often in the following situations:
1) Advanced Maternal Age
Aneuploidy risk increases with age, and structured embryo selection may be considered in certain cases.
2) Recurrent Miscarriage
When pregnancy losses may be linked to chromosomal factors, embryo testing strategies can be discussed.
3) Repeated IVF Failure
If multiple transfers have not resulted in pregnancy, embryo testing may help clarify embryo chromosome status as one possible factor.
4) Known Genetic Risk (Single-Gene Conditions)
When there is a confirmed inherited disease risk, NGS may be part of a broader PGT-M testing strategy, depending on the program design.
5) Known Chromosomal Rearrangements
When one partner has a translocation or structural rearrangement, embryo testing can help guide transfer decisions.
Not every IVF patient needs embryo testing. The decision should be personalized and based on medical indication.
Step-by-Step: How NGS Is Used in IVF in Georgia (Tbilisi)
Step 1: Consultation and Genetic Planning
Your fertility specialist reviews:
-
medical history and diagnosis
-
genetic reports (if available)
-
family history and previous pregnancy history
-
whether embryo testing is appropriate and which type (PGT-A, PGT-M, PGT-SR)
Step 2: IVF/ICSI to Create Embryos
Embryos must be created through IVF. Many testing cycles use ICSI to support controlled fertilization conditions.
Step 3: Embryo Culture and Monitoring
Embryos develop in the lab for several days. Only embryos that reach the appropriate stage are considered for biopsy.
Step 4: Embryo Biopsy
A small number of cells are removed from the embryo by trained embryologists. The embryo is typically frozen afterward in many testing workflows.
Step 5: NGS Laboratory Analysis
The biopsy sample is processed and analyzed using NGS. The report helps classify embryos according to the goal of testing, such as:
-
chromosomally normal (euploid)
-
chromosomally abnormal (aneuploid)
-
sometimes mosaic or inconclusive (depending on reporting rules)
Step 6: Frozen Embryo Transfer (FET) Planning
Because genetic testing takes time, transfer is often planned as FET once results are ready. The uterus is prepared carefully, and transfer is scheduled for the best timing.
What NGS Can and Cannot Tell You
What NGS Can Support
-
embryo chromosome screening strategy for selected IVF cases
-
targeted testing for specific inherited risks when planned correctly
-
more informed embryo selection before transfer
What NGS Cannot Guarantee
-
pregnancy or live birth
-
elimination of all genetic risks
-
a complete “health check” for every possible condition
-
replacement of prenatal testing and pregnancy follow-up
Key Limitations Patients Should Understand
-
Mosaicism: embryos can contain a mix of normal and abnormal cells; biopsy samples only a few cells.
-
No-result cases: sometimes the sample does not produce a clear report.
-
Not always necessary: for some patients with a strong prognosis, standard IVF transfer without testing may be recommended first.
-
Outcome depends on the full medical plan: embryo selection is only one part of IVF success.
International Patient Timeline in Georgia
Many international patients plan NGS-based testing in two phases:
-
IVF/ICSI cycle, embryo biopsy, and freezing
-
Return for FET after results are available (or plan a longer stay depending on timing)
Your best timeline depends on ovarian response, embryo development, and your preferred travel schedule.